Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|October 19, 2007
Discovery of dibenzo[c,f][2,7]naphthyridines as potent and selective 3-phosphoinositide-dependent kinase-1 inhibitorsAriamala Gopalsamy, Mengxiao Shi, Diane H Boschelli, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2008
Synthesis and evaluation of acylguanidine FXa inhibitorsStephen P O'Connor, Karnail Atwal, Chi Li, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2009
Hit to lead optimization of pyrazolo[1,5-a]pyrimidines as B-Raf kinase inhibitorsAriamala Gopalsamy, Greg Ciszewski, Mengxiao Shi, et al.
Journal of Medicinal Chemistry|December 5, 2008
Identification of diarylsulfone sulfonamides as secreted frizzled related protein-1 (sFRP-1) inhibitorsAriamala Gopalsamy, Mengxiao Shi, Barbara Stauffer, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2009
Identification of iminooxothiazolidines as secreted frizzled related protein-1 inhibitorsMengxiao Shi, Barbara Stauffer, Ramesh Bhat, et al.
Journal of Medicinal Chemistry|January 17, 2008
Discovery of benzisoxazoles as potent inhibitors of chaperone heat shock protein 90Ariamala Gopalsamy, Mengxiao Shi, Jennifer Golas, et al.
The Journal of Biological Chemistry|October 13, 2011
Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseasesJingsong Cao, Yingjiang Zhou, Haibing Peng, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitorsYan Shi, Jing Zhang, Mengxiao Shi, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
Aroylguanidine-based factor Xa inhibitors: the discovery of BMS-344577Yan Shi, Chi Li, Stephen P O'Connor, et al.
Pageof 3